2019-05-09

Putting Viral Clearance Capabilities to the Test - Vironova Biosafety

  Best practices from Vironova Biosafety. Vironova Biosafety specialize in viral clearance studies for biological drugs. These kinds of drug products based on live cells have an inherent risk for viral contamination that could cause serious harm or...

2019-04-09

Third China Innovation & Entrepreneurship International Competition

We are in the finals of the Third China Innovation & Entrepreneurship International Competition in Shenzhen.   Vironova won the "Swedish Overseas Division Competition" on March 26th in the "Third China Innovation & Entrepreneurship International...

2019-03-26

Meet us at the 3rd Gene Therapy for Rare Disorders Conference

Vironova are attending the conference in Boston to follow key industry trends, and join the conversation in the field of gene therapy. March 26-28, Boston, Massachusetts, USA

2019-03-18

Meet Vironova at Bioprocessing Summit Europe 2019

Meet Vironova at Bioprocessing Summit Europe 2019 Bioprocessing , March 19-21, Lisbon, Portugal. Vironova's Marketing Director Nina Forsberg will host and moderate a Round table, 19th of March at 16:45 on the topics and needs for analytical methods...

2019-03-08

Webinar: Meaningful analytics data for quick decision making in development of viral vector-based therapies

In both early-stage and late-stage development operations of viral vector-based therapies - such as gene therapies, vaccines, or oncolytic virotherapy - access to accurate analytical data is critical. Reduction of risk and quick decision making...

2019-03-01

Sports Holiday Greeting from our COO Maria Homman

All of us at Vironova would like to take this opportunity to wish you an active and relaxing, “sports holiday”. If you have the privilege of being employed and living in Sweden, we currently have a week’s holiday to focus on fun activities. Resting...

2019-02-28

Download our new AAV gene therapy vectors application note

Download our new AAV gene therapy vectors application note Are you interested in characterization of AAV gene therapy vectors? Now you can download our new application note and find out how Vironova's MiniTEM:

2019-02-15

Vironova at ISBioTech 9th Spring meeting

meet us at ISBioTech 9th Spring meeting 2019 For more information on the prMarch 4-6, Norfolk,Virginia, USA

2019-02-06

Vironova at NEUBIAS conference

Vironova is represented this week by Ida-Maria Sintorn at the NEUBIAS symposium in Luxembourg. The 3rd Annual Conference of NEUBIAS, gathers the whole BioImage Analysis Community into a fully-packed event with aspects of bioimage analysis in life...

2019-01-29

MiniTEM™ for quality analysis of phage preparations

  Poster presentation at the Phage Future Congress 2019 On January 29th Vironova will be attending The Phage Futures Congress in Washington D.C. to follow key industry trends together with peers from biotech companies and academia. Experts from...

Upcoming events

Webinars

On demand webinars: See all available positions